Supplementary Material for: Safety profile of intravitreal Dexamethasone implant to manage diabetic macular edema: A systematic review of real-world studies.
Introduction: With increasing experience using intravitreal dexamethasone implant (DEX-i), it has become a first-line therapy in patients with diabetic macular edema (DME), due mainly to its good efficacy profile. However, this treatment is not devoid of adverse events, which are predominantly trans...
Saved in:
| Main Author: | figshare admin karger (2628495) (author) |
|---|---|
| Other Authors: | Querques G. (4127662) (author), Figus M. (21530987) (author), DeBernardo M. (21530990) (author), Toro M.D. (21530993) (author), Gharbiya M. (20301051) (author), Gallinaro V. (21530996) (author), Strina E. (21530999) (author), Cacace V. (21531002) (author), Nicolò M. (21531005) (author) |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravitreal Dexamethasone Implants for Macular Edema Secondary to Acute Retinal Necrosis
by: Peipei Wu (531528)
Published: (2025) -
Supplementary Material for: Early vs late switch to an intravitreal Dexamethasone implant after failed Anti-VEGF therapy for diabetic macular edema: A systematic review and meta-analysis
by: figshare admin karger (2628495)
Published: (2025) -
Table 1_Intravitreal aflibercept for diabetic macular edema: structural and functional improvements.docx
by: Chuanhe Zhang (17601519)
Published: (2025) -
Subgroup analysis of the efficacy and safety of dexamethasone or triamcinolone combined with anti-VEGF therapy for diabetic macular edema.
by: Bo Zhou (15092)
Published: (2025) -
Pooled effect of the efficacy and safety of dexamethasone or triamcinolone combined with anti-VEGF therapy for diabetic macular edema.
by: Bo Zhou (15092)
Published: (2025)